Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in NVS — Novartis AG

CIK 1323645 PARIS, I0

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
16 quarters on record

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Derivatives in NVS

reported options exposure · as of Jun 30, 2026
CallValue
$2,319,456
CallShares
14,800
PutValue
$9,262,152
PutShares
59,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $132,289,562 across 6 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,319,456 14,800
2026-06-30 $9,262,152 59,100
2026-03-31 $22,164,025 145,100
2026-03-31 $4,857,450 31,800
2025-12-31 $20,087,659 145,700
2025-12-31 $24,458,138 177,400
2025-09-30 $8,207,360 64,000
2025-09-30 $9,977,072 77,800
2025-06-30 $16,566,269 136,900
2025-06-30 $5,856,884 48,400
2025-03-31 $3,522,768 31,600
2025-03-31 $1,246,011 11,177
2025-03-31 $17,312,844 155,300
2024-12-31 $6,597,618 67,800
2024-12-31 $2,218,668 22,800
2024-09-30 $1,782,810 15,500
2024-06-30 $1,245,582 11,700
2024-06-30 $1,724,652 16,200
2024-03-31 $2,408,577 24,900
2024-03-31 $1,489,642 15,400
2023-12-31 $1,484,259 14,700
2023-12-31 $1,635,714 16,200
2022-12-31 $1,288,224 14,200
2020-12-31 $1,132,782 11,996
2020-09-30 $1,749,026 20,113
2020-09-30 $930,472 10,700
2020-06-30 $7,110,873 81,416
2020-03-31 $1,954,065 23,700
2020-03-31 $13,307,677 161,403
2020-03-31 $2,333,335 28,300